Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Net Debt
$686.70M
Quarterly · Period ending: · USD
BIO Net Debt
Latest reported$686.70Mperiod ending
Latest reported$686.70Mperiod ending
BIO Quarterly Net Debt ($18.90M → $686.70M)
Quarterly net debt
High-resolution chart · PNG
BIO net debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Debt (USD) |
|---|---|
| 185,983,000 | |
| 210,899,000 | |
| 207,552,000 | |
| 216,830,000 | |
| 249,428,000 | |
| 256,546,000 | |
| 244,100,000 | |
| 33,300,000 | |
| 37,600,000 | |
| 43,200,000 | |
| 41,600,000 | |
| 40,400,000 | |
| 44,700,000 | |
| 44,000,000 | |
| 39,000,000 | |
| 4,500,000 | |
| 3,200,000 | |
| 5,800,000 | |
| 2,900,000 | |
| 3,400,000 | |
| 900,000 | |
| 13,100,000 | |
| 20,400,000 | |
| 32,400,000 | |
| 38,700,000 | |
| 42,100,000 | |
| 44,100,000 | |
| 51,900,000 | |
| 55,400,000 | |
| 64,700,000 | |
| 75,500,000 | |
| 96,200,000 | |
| 100,100,000 | |
| 93,000,000 | |
| 91,600,000 | |
| 88,300,000 | |
| 104,100,000 | |
| 91,900,000 | |
| 91,800,000 | |
| 88,300,000 | |
| 74,900,000 | |
| 72,400,000 | |
| 68,900,000 | |
| 61,200,000 | |
| 58,900,000 | |
| 54,900,000 | |
| 57,600,000 | |
| 54,400,000 | |
| 55,500,000 | |
| 49,100,000 | |
| 48,900,000 | |
| 29,600,000 | |
| 18,900,000 |